interleukin-8 and Carcinoma--Embryonal

The interleukin-8 promoter is transcriptionally activated by interleukin-1, tumor necrosis factor alpha, phorbol myristate acetate, or hepatitis B virus X protein through a sequence located between positions -91 and -71. This region contains an NF-kappa B-like and a C/EBP-like binding site. We show here that several members of the NF-kappa B family, including p65, p50, p52, and c-Rel, can bind to this region, confirming an authentic NF-kappa B binding site in the interleukin-8 promoter. Further, C/EBP binds only weakly to the interleukin-8 promoter site. Electrophoretic mobility shift assays with proteins overexpressed in COS cells and with nuclear extracts from tumor necrosis factor alpha-stimulated HeLa cells demonstrated a strong cooperative binding of C/EBP to its site when NF-kappa B is bound to its adjacent binding site. Transfection studies lead to a model that suggests a highly complex regulation of interleukin-8 gene expression at multiple levels: independent binding of C/EBP and NF-kappa B to their respective sites, cooperative binding of C/EBP and NF-kappa B to DNA, and positive synergistic activation through the C/EBP binding site and inhibition through the NF-kappa B binding site by combinations of C/EBP and NF-kappa B. Thus, the ultimate regulation of interleukin-8 gene expression depends on the ratio of cellular C/EBP and NF-kappa B.

Topics: Animals; Base Sequence; Binding Sites; Carcinoma, Embryonal; CCAAT-Enhancer-Binding Proteins; Cell Line; DNA-Binding Proteins; Gene Expression Regulation; Genes, fos; HeLa Cells; Humans; Interleukin-1; Interleukin-8; Kinetics; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; NF-kappa B; Nuclear Proteins; Oligodeoxyribonucleotides; Point Mutation; Promoter Regions, Genetic; Tetradecanoylphorbol Acetate; Trans-Activators; Transcription Factors; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Viral Regulatory and Accessory Proteins